Wagner Paul A. has filed 34 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 1250 shares of Forte Biosciences, Inc. ($FBRX) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Common Stock | 1250 | $0.00 | 84,428.0000 | 12,526,935 | 1.50% | 0.01% |
| April 1, 2026 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Restricted Stock Units | 1250 | $0.00 | 3,750.0000 | 12,526,935 | 25.00% | 0.01% |
| April 1, 2026 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | F | Common Stock | 98 | $24.86 | 84,330.0000 | 12,526,935 | 0.12% | 0.00% |
| Jan. 12, 2026 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | A | Stock Option (right to buy) | 270000 | $0.00 | 270,000.0000 | 12,526,935 | 9999.99% | 2.16% |
| Jan. 12, 2026 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | A | Restricted Stock Units | 180000 | $0.00 | 180,000.0000 | 12,526,935 | 9999.99% | 1.44% |
| Jan. 1, 2026 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Common Stock | 1250 | $0.00 | 83,342.0000 | 12,526,935 | 1.52% | 0.01% |
| Jan. 1, 2026 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Restricted Stock Units | 1250 | $0.00 | 5,000.0000 | 12,526,935 | 20.00% | 0.01% |
| Jan. 1, 2026 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | F | Common Stock | 164 | $27.27 | 83,178.0000 | 12,526,935 | 0.20% | 0.00% |
| Oct. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Restricted Stock Units | 1250 | $0.00 | 6,250.0000 | 6,581,667 | 16.67% | 0.02% |
| Oct. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Common Stock | 1250 | $0.00 | 82,190.0000 | 6,581,667 | 1.54% | 0.02% |
| Oct. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | F | Common Stock | 98 | $14.52 | 82,092.0000 | 6,581,667 | 0.12% | 0.00% |
| July 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Common Stock | 1250 | $0.00 | 81,038.0000 | 6,581,667 | 1.57% | 0.02% |
| July 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | F | Common Stock | 98 | $12.44 | 80,940.0000 | 6,581,667 | 0.12% | 0.00% |
| July 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Restricted Stock Units | 1250 | $0.00 | 7,500.0000 | 6,581,667 | 14.29% | 0.02% |
| April 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Restricted Stock Units | 1250 | $0.00 | 8,750.0000 | 6,581,667 | 12.50% | 0.02% |
| April 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Common Stock | 1250 | $0.00 | 79,806.0000 | 6,581,667 | 1.59% | 0.02% |
| April 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | F | Common Stock | 18 | $7.43 | 79,788.0000 | 6,581,667 | 0.02% | 0.00% |
| March 20, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | A | Stock Option (right to buy) | 920000 | $0.00 | 920,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Restricted Stock Units | 1250 | $0.00 | 10,000.0000 | 0 | 11.11% | 0.00% |
| Jan. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Common Stock | 1250 | $0.00 | 78,720.0000 | 0 | 1.61% | 0.00% |
| Jan. 1, 2025 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | F | Common Stock | 164 | $22.71 | 78,556.0000 | 0 | 0.21% | 0.00% |
| Oct. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Restricted Stock Units | 1250 | $0.00 | 11,250.0000 | 0 | 10.00% | 0.00% |
| Oct. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | F | Common Stock | 98 | $5.16 | 77,470.0000 | 0 | 0.13% | 0.00% |
| Oct. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Common Stock | 1250 | $0.00 | 77,568.0000 | 0 | 1.64% | 0.00% |
| July 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | F | Common Stock | 2453 | $0.55 | 1,907,971.0000 | 0 | 0.13% | 0.00% |
| July 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Restricted Stock Units | 31250 | $0.00 | 312,500.0000 | 0 | 9.09% | 0.00% |
| July 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Common Stock | 31250 | $0.00 | 1,910,424.0000 | 0 | 1.66% | 0.00% |
| April 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Restricted Stock Units | 31250 | $0.00 | 343,750.0000 | 0 | 8.33% | 0.00% |
| April 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | F | Common Stock | 2453 | $0.71 | 1,879,174.0000 | 0 | 0.13% | 0.00% |
| April 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | M | Common Stock | 31250 | $0.00 | 1,881,627.0000 | 0 | 1.69% | 0.00% |
| March 21, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | SEE REMARKS | A | Stock Option (right to buy) | 1100000 | $0.00 | 1,100,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | See Remarks | F | Common Stock | 4109 | $0.82 | 1,850,377.0000 | 0 | 0.22% | 0.00% |
| Jan. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | See Remarks | M | Restricted Stock Units | 31250 | $0.00 | 375,000.0000 | 0 | 7.69% | 0.00% |
| Jan. 1, 2024 | Forte Biosciences, Inc. | $FBRX | Wagner Paul A. | See Remarks | M | Common Stock | 31250 | $0.00 | 1,854,486.0000 | 0 | 1.71% | 0.00% |